In women, the vagina, cervix, uterus, Fallopian tubes, ovaries and, in some cases, the vulva are removed.

Pelvic exenteration often leads to complications, such as infection, kidney damage, embolism, perineal hernia, and problems with the stomas created.

[3] This can happen if there are metastases in the liver, the sidewall of the pelvic cavity, the aortic lymph nodes, or through carcinosis.

In women, the vagina, cervix, uterus, fallopian tubes, ovaries and, in some cases, the vulva are removed.

A 2015 article reports that pelvic exenteration can provide long-term survival for patients with locally advanced primary rectal carcinoma.

The 5-year survival rate of patients undergoing pelvic exenteration following complete resection of disease was 59.3%.

Factors shown to influence the survival rate following a pelvic exenteration procedure include age, the presence of metastatic disease, lymph node status, circumferential resection margin, local recurrence of disease, and the need for neoadjuvant therapy.